Home
Momchilo Vuyisich
Functional Food Talks
Dairy Talks
Founding Chief Science Officer and Head of Clinical Research
Viome Life Sciences

Dr Vuyisich is a co-founder, Chief Science Officer, and Head of Clinical Research at Viome Life Sciences. His passion is to use science and technology to improve human health, with focus on disease prevention using data-driven personalized nutrition. He has used his extensive scientific expertise and business acumen to lead the development of advanced technologies and their application towards a healthier future. These technologies are enabling the transformation of the current healthcare, which focuses on symptoms management, into a novel preventive and curative model, where individuals can take control of their own health and maintain a long health span.

Dr Vuyisich has an undergraduate degree in Microbiology and a PhD in Biochemistry. He has published more than 45 peer-reviewed scientific articles.


Event Introduction
Functional Food Talks
 · 04/28 (Day 2)
Explore The Next Star Ingredient
Cyber Nutrition
09:40
Talking to Your ‘Cyber Colleague’: AI-Driven Precision Nutrition

AI is not just transforming data—it’s redefining how we understand the human body. What once seemed impossible in precision nutrition—decoding the complex interplay of genes, biomarkers, and metabolism—is now within reach.

Pioneers like Viome Life Sciences (AI + RNA, $175M funded) are proving the power of intelligent nutrition, using RNA sequencing to detect early health risks and deliver personalized dietary solutions that have clinically reduced IBS symptoms by 58% and anxiety by 31%.

In this new era, AI becomes more than a tool—it’s the nutritionist’s “cyber colleague,” bridging science and human vitality in ways never before imagined.

Link to agenda
Dairy Talks
 · 04/28 (Day 2)
Hit New Category
Nutrition Upgrade
11:10
[Panel Discussion] GLP-1 and Post-GLP-1 Market

GLP-1 drugs are sweeping the globe, reshaping the weight management landscape.

Yet as questions around efficacy, side effects, cost, and accessibility emerge, growing attention is shifting to the “post-GLP-1 era.” Diverse approaches—ranging from nutritional interventions and functional foods to metabolic health formulations—are entering the field.

What structural changes has the GLP-1 boom already triggered? And as the market normalizes or cools, where will the next wave of innovation and business opportunities in weight management arise? Where are the advantages and opportunities for dairy enterprises?

Link to agenda